Beyond Air, Inc. — Director's Dealing 2024

Oct 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beyond Air, Inc. (XAIR)
CIK: 0001641631
Period of Report: 2024-09-26

Reporting Person: Carey Robert (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-26	Common Stock	P	1476626	$0.5043	Acquired	1476626	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-26	Pre-funded Warrants to purchase Common Stock	$0.0001	P	26142	Acquired		Common Stock (26142)	Indirect
2024-09-26	Pre-funded Warrants to purchase Common Stock	$0.0001	P	480179	Acquired		Common Stock (480179)	Indirect
2024-09-26	Warrants to purchase Common Stock	$0.3793	P	102382	Acquired		Common Stock (102382)	Indirect
2024-09-26	Warrants to purchase Common Stock	$0.3793	P	1880565	Acquired		Common Stock (1880565)	Indirect
2024-09-27	Warrants to purchase Common Stock	$0.3793	J	9886633	Acquired		Common Stock (9886633)	Indirect

Footnotes

F1: Pursuant to a Securities Purchase Agreement (the "Agreement"), dated as of September 26, 2024, by and between Beyond Air, Inc. (the "Issuer") and Steven Lisi (the "Reporting Person"), the Reporting Person acquired in a private placement transaction 1,476,626 shares of common stock, $0.0001 par value per share (the "Common Stock"), pre-funded warrants to acquire 506,321 shares of Common Stock at an exercise price of $0.0001 per share, and common warrants to acquire 1,982,947 shares of Common Stock at an exercise price of $0.3793 per share.

F2: The pre-funded warrants will be exercisable on or after the date on which the Company obtains stockholder approval (the "Initial Exercise Date"), as further described in the Agreement and in the Issuer's Current Report on Form 8-K filed with the SEC on September 27, 2024, and shall expire when exercised in full.

F3: Each pre-funded warrant was purchased with an accompanying warrant for a purchase price of $0.5042 per pre-funded warrant and accompanying warrant.

F4: The common warrants are exercisable on or after the Initial Exercise Date and will have a term that expires five years following the Initial Exercise Date.

F5: Each common share was purchased with an accompanying warrant for a purchase price of $0.5043 per share and accompanying warrant.

F6: Pursuant to a binding term sheet dated as of September 27, 2024, and in connection with a loan to the Issuer of $7,500,000, the Reporting Person acquired warrants to purchase up to 9,886,633 shares of Common Stock.

F7: The warrants issuable will be exercisable on or after the Initial Exercise Date and will expire five years following such date they are exercisable.